Cargando…
Lenalidomide improves NKG2D-based CAR-T cell activity against colorectal cancer cells invitro
INTRODUCTION: Although CAR-based immunotherapy is viewed as a promising treatment for tumors, particularly hematological malignancies, solid tumors can pose challenges. It has been suggested that the immunomodulatory medication Lenalidomide (LEN) may increase the effectiveness of CAR T cells in the...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543764/ https://www.ncbi.nlm.nih.gov/pubmed/37790973 http://dx.doi.org/10.1016/j.heliyon.2023.e20460 |